Contact
searchSearch
HMP Global

Thinking Outside the Bowel: Extra-Intestinal Manifestations “Disease vs Drug Related”

AIBD

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Popular Articles

Joshua Baker, MD, on the Risk of Diabetes Among Patients With RA
Videos
Joshua Baker, MD, on the Risk of Diabetes Among Patients With RA
07/29/2021
In this video, Dr Joshua Baker, an assistant professor of rheumatology and epidemiology at the University of Pennsylvania, discusses the risk of diabetes among patients with rheumatoid arthritis.
In this video, Dr Joshua Baker, an assistant professor of rheumatology and epidemiology at the University of Pennsylvania, discusses the risk of diabetes among patients with rheumatoid arthritis.
In this video, Dr Joshua Baker,...
07/29/2021
Rheumatology & Arthritis
Trials in Rheumatology: IL-6 and Beyond
Videos
Trials in Rheumatology: IL-6 and Beyond
02/08/2021
In this video, Leonard Calabrese, DO, and Cassandra Calabrese, DO, discuss their experiences with the COVID-19 pandemic, including the ongoing drug trials at the Cleveland Clinic. Read the transcript here. Additional Resource:
In this video, Leonard Calabrese, DO, and Cassandra Calabrese, DO, discuss their experiences with the COVID-19 pandemic, including the ongoing drug trials at the Cleveland Clinic. Read the transcript here. Additional Resource:
In this video, Leonard...
02/08/2021
Rheumatology & Arthritis
A Preview of the ACR Guideline for the Management of JIA
Videos
A Preview of the ACR Guideline for the Management of JIA
12/01/2020
The American College of Rheumatology (ACR) guideline for the management of juvenile idiopathic arthritis (JIA) is currently under review and will soon be published. In this video, the lead investigator of the guideline’s Core Team, Karen...
The American College of Rheumatology (ACR) guideline for the management of juvenile idiopathic arthritis (JIA) is currently under review and will soon be published. In this video, the lead investigator of the guideline’s Core Team, Karen...
The American College of...
12/01/2020
Rheumatology & Arthritis
FDA Approves Treatment Option for Polyarticular Course JIA
FDA Approves Treatment Option for Polyarticular Course JIA
10/01/2020
The US Food and Drug Administration (FDA) has approved Xeljanz (tofacitinib) for the treatment of active polyarticular course juvenile idiopathic arthritis (pcJIA) among pediatric patients aged 2 years or older. The...
The US Food and Drug Administration (FDA) has approved Xeljanz (tofacitinib) for the treatment of active polyarticular course juvenile idiopathic arthritis (pcJIA) among pediatric patients aged 2 years or older. The...
The US...
10/01/2020
Rheumatology & Arthritis
Which Patients With Psoriasis Are More Likely to Develop PsA?
Which Patients With Psoriasis Are More Likely to Develop PsA?
06/26/2020
Patients with psoriasis who also have structural entheseal lesions, even when they have no clinical symptoms of musculoskeletal disease, are at a higher risk of developing psoriatic arthritis (PsA) than patients...
Patients with psoriasis who also have structural entheseal lesions, even when they have no clinical symptoms of musculoskeletal disease, are at a higher risk of developing psoriatic arthritis (PsA) than patients...
Patients...
06/26/2020
Rheumatology & Arthritis

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use